✦ LIBER ✦

Validation and clinical utility of prostate cancer biomarkers

✍ Scribed by Scher, Howard I.; Morris, Michael J.; Larson, Steven; Heller, Glenn

Book ID: 120053635
Publisher: Nature Publishing Group
Year: 2013
Tongue: English
Weight: 511 KB
Volume: 10
Category: Article
ISSN: 1759-4774
DOI: 10.1038/nrclinonc.2013.30

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Breast Cancer Biomarkers: Utility in Cli

Breast Cancer Biomarkers: Utility in Clinical Practice

✍ Du, Fanny; Ueno, Naoto T.; Gonzalez-Angulo, Ana M. 📂 Article 📅 2013 🏛 Springer-Verlag 🌐 English ⚖ 217 KB

Validation of surrogate endpoint biomark

Validation of surrogate endpoint biomarkers in prostate cancer chemoprevention trials

✍ Bruce J Trock 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 210 KB

The role of proteomics in prostate cance

The role of proteomics in prostate cancer research: Biomarker discovery and validation

✍ Pin, Elisa; Fredolini, Claudia; Petricoin, Emanuel F. 📂 Article 📅 2013 🏛 Elsevier Science 🌐 English ⚖ 683 KB

Biomarkers for prostate cancer

✍ Eddy S. Leman; Robert H. Getzenberg 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 86 KB

## Abstract The detection of prostate cancer using a blood test has by many standards changed the face of the disease. Despite this tremendous success, there are limitations attributed to the use of prostate specific antigen (PSA) as a means to screen and detect prostate cancer. PSA, as its name im

Clinical proteomics: Applications for pr

Clinical proteomics: Applications for prostate cancer biomarker discovery and detection

✍ Emanuel F Petricoin; David K Ornstein; Lance A Liotta 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 329 KB

Validation study of urinary metabolites

Validation study of urinary metabolites as potential biomarkers for prostate cancer detection

✍ Gamagedara, Sanjeewa; Kaczmarek, Anthony T; Jiang, Yongqing; Cheng, Xiaoliang; R 📂 Article 📅 2012 🏛 Future Science 🌐 English ⚖ 833 KB